Search - tctmd.com

Displaying 1 - 9 of 9

Sort: Relevancy | Date

AGENT IDE: DCB Performance for In-Stent Restenosis Lasts Out to 2 Years

News Conference News CRT 2025

AGENT IDE: DCB Performance for In-Stent Restenosis Lasts Out to 2 Years

March 10, 2025

Full AGENT IDE Results Affirm Benefits of DCB for In-Stent Restenosis

News Conference News CRT 2024

Full AGENT IDE Results Affirm Benefits of DCB for In-Stent Restenosis

March 09, 2024

In CABG/PCI Decisions for Left Main Disease, Diabetes ‘Still Matters’

News Conference News CRT 2023

In CABG/PCI Decisions for Left Main Disease, Diabetes ‘Still Matters’

Yael L. Maxwell

March 01, 2023

Meta-analysis Shows Similar 5-Year Mortality for PCI, CABG in Left Main Disease

News Daily News CRT 2020

Meta-analysis Shows Similar 5-Year Mortality for PCI, CABG in Left Main Disease

Michael O'Riordan

March 04, 2020

PCI-Related MIs Not Linked to Mortality at 1 Year: Onyx ONE

News Conference News CRT 2020

PCI-Related MIs Not Linked to Mortality at 1 Year: Onyx ONE

Michael O'Riordan

February 25, 2020

CABG vs PCI in Left Main Disease: The Debate Continues

News Conference News CRT 2019

CABG vs PCI in Left Main Disease: The Debate Continues

Yael L. Maxwell

March 12, 2019

Radial Access PCI Reduces Risk of Mortality and Bleeding in VALIDATE-SWEDEHEART

News Conference News CRT 2018

Radial Access PCI Reduces Risk of Mortality and Bleeding in VALIDATE-SWEDEHEART

Michael O'Riordan

March 06, 2018

Acute MI Patients With Paraplegia Rarely Get Revascularization, Face Higher Risk of Death

News Conference News CRT 2018

Acute MI Patients With Paraplegia Rarely Get Revascularization, Face Higher Risk of Death

March 05, 2018

Is COAPT Designed to Fail? Experts Debate Treatment Timing in Severe Functional MR

News Conference News CRT 2018

Is COAPT Designed to Fail? Experts Debate Treatment Timing in Severe Functional MR

Michael O'Riordan

March 05, 2018

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.